Skip to main content

Table 1 Clinical characteristics of patients with pneumatosis intestinalis

From: Multicenter epidemiological survey of pneumatosis intestinalis in Japan

Characteristics

n

(%)

No. patients

167

 

Men/women

87/80

 

Median age of onset (years)

65 (range 9–91)

 

Exposure to organic solvents

2

(1)

Comobidities and/or past medical history

141

(84)

 Gastroduodenal diseases

45

(27)

  Inflammatory bowel disease

16

(10)

   Ulcerative colitis

13

(8)

   Crohn's disease

2

(1)

   Behcet's disease

1

(1)

  Carcinoma

13

(8)

   Esophegeal carcinoma

1

(1)

   Gastric carcinoma

3

(2)

   Colorectal carcinoma

9

(5)

  Colorectal polyp

6

(4)

  Bowel obstruction

3

(2)

  Others

5

(3)

 Diabetes mellitus

31

(19)

 Chronic lung disease

28

(17)

 Autoimmune disease

30

(18)

 Hypertension

13

(8)

 Heart disease

11

(7)

 Hepatobiliarypancreatic disease

10

(6)

 Kideny disease

4

(2)

 Others

41

(25)

Medications used

137

(82)

 Corticosteroid

45

(27)

 Antidiabetics

29

(17)

  α-glucosidase inhibitors

23

(14)

  Others

14

(8)

 Gastric acid secretion inhibitors

20

(12)

  Proton pump inhibitors

15

(9)

  Histamine-2 receptor antagonists

6

(4)

 Antihypertensives

19

(11)

  Calcium antagonist

10

(6)

  β-blocker

8

(5)

  Angiotensin II receptor blocker

9

(5)

  Angiotensin converting enzyme inhibitor

1

(1)

  α-blocker

1

(1)

 Immunosuppressants

16

(10)

 5-aminosalicylates or salicylazosulfapyridine

15

(9)

 Statins/ezetimib/fibrates

14

(8)

 Antithrombotics

12

(7)

  Anticoagulants

4

(2)

  Antiplatelets

9

(5)

 Laxatives*

10

(6)

 Anti-cancer agents

9

(5)

 Herbal medicine

7

(4)

 Allopurinol/benzbromaron

3

(2)

 Others

44

(26)

  1. *Magnesium oxide (n = 7), sennoside (n = 4), and sodium picosulfate (n = 4)